Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin
- 1 June 1998
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 247 (3), 610-615
- https://doi.org/10.1006/bbrc.1998.8697
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences of the United States of America, 1998
- Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesisin Vitro1Endocrinology, 1998
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997
- TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T CellsPublished by Elsevier BV ,1997
- Regulation of Osteoclast FunctionJournal of Bone and Mineral Research, 1997
- Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits OsteoclastogenesisBiochemical and Biophysical Research Communications, 1997
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- Modulation of osteoclast differentiation by local factorsBone, 1995
- The Bone Marrow-Derived Stromal Cell Lines MC3T3-G2/PA6 and ST2 Support Osteoclast-Like Cell Differentiation in Cocultures with Mouse Spleen CellsEndocrinology, 1989
- OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATIONEndocrinology, 1988